Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome

British Journal of Rheumatology

Volumn 37, Issue 11, 1998, Pages 1229-1232

  Bertolaccini, M L ^a   Roch, B ^a   Amengual, O ^a   Atsumi, T ^a   Khamashta, M A ^a   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anticardiolipin antibodies; Antiphosphatidylethanolamine; Lupus anticoagulant; Systemic lupus erythematosus; Thrombosis

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 0031761048     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize β2-Glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
2. Oosting JD, Derksen RHWM, Bobbink IWG, Hackeng TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with Prothrombin, Protein C, or Protein S: an explanation for their pathogenic mechanism? Blood 1993;81:2618-25.
3. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostasis 1991;66:629-32.
4. Galli M. Non β2-glycoprotein cofactors for antiphospholipid antibodies. Lupus 1996;5:388-92.
5. Karmochkine M, Berard M, Piette JC et al. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus 1993;2:157-60.
6. Adler Y, Finkelstein Y, Zandeman-Goddard G et al. The presence of antiphospholipid antibodies in acute myocardial infarction. Lupus 1995;4:309-13.
7. Berard M, Chantome R, Marcelli A, Boffa MC. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous disease. J Rheumatol 1996;23:1369-74.
8. Lopez-Soto A, Cervera R, Font J et al. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. Clin Exp Rheumatol 1997;15:143-9.
9. Smirnov MD, Triplett DT, Comp PC, Esmon NL, Esmon CT. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 1995;95:309-16.
10. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
11. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
12. Gilman-Sachs A, Lubinski J, Beer AE, Brend S, Beaman KD. Patterns of antiphospholipid antibody specificities. J Clin Lab Immunol 1991;35:83-8.
13. Toschi V, Motta A, Castelli C et al. Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus. Haemostasis 1993;23:275-83.
14. Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR. Studies of IgG, IgM and IgA antiphospholipid antibody isotype in systemic lupus erythematosus. J Rheumatol 1988;15:74-9.
15. Boffa MC, Berard M, Sugi T, McIntyre A. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity. J Rheumatol 1996;23:1375-9.
16. Cervera R, Font J, Lopez-Soto A et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 1990;49:109-13.
17. Delezé M, Oria CV, Alarcón Segovia D. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1988;15:611-5.
18. Branch DW, Rote NS, Dostal DA, Scott JR. Association of lupus anticoagulant with antibody to phosphatidylserine. Clin Immunol Immunopathol 1987;42:63-75.
19. Falcon CR, Hoffer AM, Carreras LO. Evaluation of the clinical and laboratory associations of antiphosphatidylethanolamine. Thromb Res 1990;63:321-2.
20. Sugi T, McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995;86:3083-9.